Achaogen Stock

Achaogen OCF/Debt

Delisted

The Operating Cash Flow to Debt Ratio of Achaogen (AKAOQ) as of Aug 13, 2026 is -331.43 %. In the previous year, Operating Cash Flow to Debt Ratio was -298.07 % — a change of 11.19% (lower).

OCF/Debt

-331.43 %

YoY

11.19%

Last updated:

Operating Cash Flow to Debt Ratio of Achaogen is 2026 -331.43 % . Operating Cash Flow to Debt Ratio of Achaogen was 2025 -298.07 % . It decreases by 11.19% lower compared to the previous year.
Access this data via the Eulerpool API

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Achaogen stock

Operating Cash Flow to Debt Ratio of Achaogen is -331.43 % in 2026.

Operating Cash Flow to Debt Ratio of Achaogen changed from -298.07 % to -331.43 %, representing a 11.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Achaogen since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Achaogen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Achaogen

All Key Metrics — Achaogen